Since Trump took office, officials have transferred ten of the 37 men Biden spared from execution to the "Alcatraz of the Rockies." One prisoner still awaiting transfer has attempted suicide.

The leaked internal chat communications of the Black Basta ransomware group offer an unprecedented view into how cybercriminals operate, plan attacks, and ...

If language is what makes us human, what does it mean now that large language models have gained “metalinguistic” abilities?

With the popularity of AI coding tools rising among some software developers, their adoption has begun to touch every aspect ...

Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...

AWS executive Sarah Cooper routinely crafts proposals to create new job roles and initiatives. Cooper uses Amazon's 6-page narrative memo and its PR/FAQ frameworks to pitch ideas. She wrote a proposal ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Call of Duty Black Ops 7 is the latest high-profile game to confirm that it uses generative AI for some of its in-game assets, according to a disclosure on its Steam page. After similar disclosures ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...